Page last updated: 2024-08-21

cyclopentane and Bile Duct Cancer

cyclopentane has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, M; Fan, J; Gao, Q; Jeong, LS; Jia, LJ; Li, LH; Qiu, SJ; Shi, JY; Wang, XY; Wang, ZC; Yang, LX; Yu, GY; Zhang, WJ; Zhao, H; Zhou, J1

Other Studies

1 other study(ies) available for cyclopentane and Bile Duct Cancer

ArticleYear
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target.
    Oncotarget, 2014, Sep-15, Volume: 5, Issue:17

    Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Separation; Cholangiocarcinoma; Cyclopentanes; Enzyme Inhibitors; Female; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; NEDD8 Protein; Neoplasm Recurrence, Local; Pyrimidines; Signal Transduction; Tissue Array Analysis; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Ubiquitins; Up-Regulation; Xenograft Model Antitumor Assays

2014